Maybe, but we’ve had several good “trial results” that did not result in a fair valuation. The federal government purchasing significant amounts of Brilacidin, (like it did with Chloroquine and Remdesivir), would put big bucks in our bank account. That will definitely result in a valuation that is more fair and appropriate.